BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32421978)

  • 1. The Role of Microbial Translocation and Immune Activation in AIDS-Associated Non-Hodgkin Lymphoma Pathogenesis: What Have We Learned?
    Epeldegui M; Hussain SK
    Crit Rev Immunol; 2020; 40(1):41-51. PubMed ID: 32421978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.
    Epeldegui M; Magpantay L; Guo Y; Halec G; Cumberland WG; Yen PK; Macatangay B; Margolick JB; Rositch AF; Wolinsky S; Martinez-Maza O; Hussain SK
    AIDS; 2018 Apr; 32(7):945-954. PubMed ID: 29424776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis.
    Guo Y; Siewe B; Epeldegui M; Detels R; Landay AL; Martínez-Maza O
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):204-10. PubMed ID: 23722608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation.
    Ramendra R; Isnard S; Mehraj V; Chen J; Zhang Y; Finkelman M; Routy JP
    Front Immunol; 2019; 10():465. PubMed ID: 30967860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of microbial translocation and risk of AIDS-related lymphoma.
    Marks MA; Rabkin CS; Engels EA; Busch E; Kopp W; Rager H; Goedert JJ; Chaturvedi AK
    AIDS; 2013 Jan; 27(3):469-74. PubMed ID: 23169327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma.
    Epeldegui M; Vendrame E; Martínez-Maza O
    Immunol Res; 2010 Dec; 48(1-3):72-83. PubMed ID: 20717742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.
    Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia RJ; Gold J; Finlayson RJ; Cooper DA; Kaldor JM
    AIDS; 2000 Jan; 14(2):133-40. PubMed ID: 10708283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.
    Piriou E; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
    Blood; 2005 Nov; 106(9):3166-74. PubMed ID: 16014568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of HIV-associated non-Hodgkin lymphoma.
    Killebrew D; Shiramizu B
    Curr HIV Res; 2004 Jul; 2(3):215-21. PubMed ID: 15279585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection.
    Cunningham-Rundles S; Ahrné S; Johann-Liang R; Abuav R; Dunn-Navarra AM; Grassey C; Bengmark S; Cervia JS
    Nutrients; 2011 Dec; 3(12):1042-70. PubMed ID: 22292110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.
    Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma.
    van Baarle D; Hovenkamp E; Callan MF; Wolthers KC; Kostense S; Tan LC; Niesters HG; Osterhaus AD; McMichael AJ; van Oers MH; Miedema F
    Blood; 2001 Jul; 98(1):146-55. PubMed ID: 11418474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
    Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro establishment of AIDS-related lymphoma cell lines: phenotypic characterization, oncogene and tumor suppressor gene lesions, and heterogeneity in Epstein-Barr virus infection.
    Gaidano G; Parsa NZ; Tassi V; Della-Latta P; Chaganti RS; Knowles DM; Dalla-Favera R
    Leukemia; 1993 Oct; 7(10):1621-9. PubMed ID: 8412324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma in four children infected with the human immunodeficiency virus. Association with Epstein-Barr Virus and treatment.
    Nadal D; Caduff R; Frey E; Hassam S; Zimmermann DR; Seigneurin JM; Plüss HJ; Seger RA
    Cancer; 1994 Jan; 73(1):224-30. PubMed ID: 8275430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.
    Carbone A; Gloghini A; Larocca LM; Capello D; Pierconti F; Canzonieri V; Tirelli U; Dalla-Favera R; Gaidano G
    Blood; 2001 Feb; 97(3):744-51. PubMed ID: 11157493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma.
    Boyle MJ; Sewell WA; Sculley TB; Apolloni A; Turner JJ; Swanson CE; Penny R; Cooper DA
    Blood; 1991 Dec; 78(11):3004-11. PubMed ID: 1659471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hitchhiker Guide to CD4
    Le Hingrat Q; Sereti I; Landay AL; Pandrea I; Apetrei C
    Front Immunol; 2021; 12():695674. PubMed ID: 34367156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.
    Younas M; Psomas C; Reynes C; Cezar R; Kundura L; Portales P; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Moranne O; Sotto A; Sabatier R; Fabbro P; Vincent T; Dunyach-Remy C; Winter A; Reynes J; Lavigne JP; Corbeau P
    Front Immunol; 2019; 10():2185. PubMed ID: 31572392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma.
    Vendrame E; Martínez-Maza O
    J Proteome Res; 2011 Jan; 10(1):113-9. PubMed ID: 20886858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.